Long-term Angiotensin II AT1 Receptor Inhibition Produces Adipose Tissue Hypotrophy Accompanied by Increased Expression of Adiponectin and PPARgamma

Overview

Journal Eur J Pharmacol

Specialty Pharmacology

Date 2006 Oct 27

PMID 17064684

Citations 63

Authors

Stefan Zorad

Jing-Tao Dou

Julius Benicky

Daniel Hutanu

Katarina Tybitanclova

Jin Zhou

Juan M Saavedra

Affiliations

Soon will be listed here.

Abstract

To clarify the mechanism of the effects of angiotensin II AT(1) receptor antagonists on adipose tissue, we treated 8 week-old male Wistar Kyoto rats with the angiotensin II AT(1) receptor antagonist Candesartan cilexetil (10 mg/kg/day) for 18 weeks. Candesartan cilexetil reduced body weight gain, decreased fat tissue mass due to hypotrophy of epididymal and retroperitoneal adipose tissue and decreased adipocyte size without changing the number of adipocytes. Candesartan cilexetil decreased serum leptin levels and epididymal leptin mRNA, increased serum adiponectin levels and epididymal adiponectin mRNA, decreased epididymal tumor necrosis factor alpha (TNFalpha) mRNA, and increased fatty acid synthase mRNA. Considered free of peroxisome proliferator-activated receptor gamma (PPARgamma) agonist activity, Candesartan cilexetil increased epididymal expression of PPARgamma mRNA. The effects of Candesartan cilexetil on adipokine production and release may be attributable to PPARgamma activation and/or decrease in adipocyte cell size. In addition, Candesartan cilexetil treatment increased the expression of epididymal angiotensin II AT(2) receptor mRNA and protein and decreased the expression of renin receptor mRNA. These results suggest that Candesartan cilexetil influences lipid metabolism in adipose tissue by promoting adipose tissue rearrangement and modulating adipokine expression and release. These effects are probably consequences of local angiotensin II AT(1) receptor inhibition, angiotensin II AT(2) receptor stimulation, and perhaps additional angiotensin II-independent mechanisms. Our results indicate that the activity of local renin-angiotensin system plays an important role in adipose tissue metabolism. The decrease in the pro-inflammatory cytokine TNFalpha and the increase in the anti-inflammatory adipokine adiponectin indicate that Candesartan cilexetil may exert significant anti-inflammatory properties.

Citing Articles

Cardioprotective Effects of Adiponectin-Stimulated Autophagy.

Tam E, Ouimet M, Sweeney G J Lipid Atheroscler. 2025; 14(1):40-53.

PMID: 39911962 PMC: 11791421. DOI: 10.12997/jla.2025.14.1.40.

Modification of adipogenesis and oxidative stress by quercetin: positive or negative impact on adipose tissue metabolism of obese diabetic Zucker rats?.

Krskova K, Dobrocsyova V, Ferenczyova K, Hricoviniova J, Kalocayova B, Dulova U J Physiol Biochem. 2024; .

PMID: 39576482 DOI: 10.1007/s13105-024-01060-9.

The Role of Local Angiotensin II/Angiotensin Type 1-receptor Mechanisms in Adipose Tissue Dysfunction to Promote Pancreatic Cancer.

Khodashahi R, Beiraghdar F, Ferns G, Ashrafzadeh K, Aliakbarian M, Arjmand M Curr Cancer Drug Targets. 2024; 24(12):1187-1194.

PMID: 38347780 DOI: 10.2174/0115680096281059240103154836.

Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023.

Clayton T, Fitch A, Bays H Obes Pillars. 2023; 8:100083.

PMID: 38125655 PMC: 10728712. DOI: 10.1016/j.obpill.2023.100083.

The Arcuate Nucleus of the Hypothalamus and Metabolic Regulation: An Emerging Role for Renin-Angiotensin Pathways.

Mehay D, Silberman Y, Arnold A Int J Mol Sci. 2021; 22(13).

PMID: 34208939 PMC: 8268643. DOI: 10.3390/ijms22137050.

References

Hattori Y, Akimoto K, Gross S, Hattori S, Kasai K . Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia. 2005; 48(6):1066-74. DOI: 10.1007/s00125-005-1766-7. View

Morsing P, Adler G, Brandt-Eliasson U, Karp L, Ohlson K, Renberg L . Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension. 1999; 33(6):1406-13. DOI: 10.1161/01.hyp.33.6.1406. View

Ran J, Hirano T, Adachi M . Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats. J Hypertens. 2005; 23(8):1525-30. DOI: 10.1097/01.hjh.0000174077.88121.19. View

Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens R, Yu L . Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2005; 69(1):105-13. DOI: 10.1038/sj.ki.5000011. View

Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K . PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001; 50(9):2094-9. DOI: 10.2337/diabetes.50.9.2094. View

Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

Weyer C, Foley J, Bogardus C, Tataranni P, Pratley R . Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 2001; 43(12):1498-506. DOI: 10.1007/s001250051560. View

Kozak L, Ailhaud G, Darimont C, Negrel R . Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology. 2001; 142(1):487-92. DOI: 10.1210/endo.142.1.7883. View

Armando I, Carranza A, Nishimura Y, Hoe K, Barontini M, Terron J . Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation Stress. Endocrinology. 2001; 142(9):3880-9. DOI: 10.1210/endo.142.9.8366. View

10.

Folch J, Lees M, SLOANE STANLEY G . A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226(1):497-509. View

11.

Fasshauer M, Paschke R, Stumvoll M . Adiponectin, obesity, and cardiovascular disease. Biochimie. 2004; 86(11):779-84. DOI: 10.1016/j.biochi.2004.09.016. View

12.

Jandeleit-Dahm K, Tikellis C, Reid C, Johnston C, Cooper M . Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens. 2005; 23(3):463-73. DOI: 10.1097/01.hjh.0000160198.05416.72. View

13.

Lazar M . PPAR gamma, 10 years later. Biochimie. 2005; 87(1):9-13. DOI: 10.1016/j.biochi.2004.10.021. View

14.

Cabassi A, Coghi P, Govoni P, Barouhiel E, Speroni E, Cavazzini S . Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab. 2005; 90(5):2888-97. DOI: 10.1210/jc.2004-1995. View

15.

Gorzelniak K, Janke J, Engeli S, Sharma A . Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm Metab Res. 2001; 33(10):625-7. DOI: 10.1055/s-2001-17911. View

16.

Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K . The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem. 2001; 276(44):41245-54. DOI: 10.1074/jbc.M103241200. View

17.

Massiera F, Ceiler D, Murakami K, Fukamizu A, Gasc J, Quignard-Boulange A . Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001; 15(14):2727-9. DOI: 10.1096/fj.01-0457fje. View

18.

Hainault I, Nebout G, Turban S, Ardouin B, Ferre P, Quignard-Boulange A . Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am J Physiol Endocrinol Metab. 2001; 282(1):E59-66. DOI: 10.1152/ajpendo.2002.282.1.E59. View

19.

Pinterova L, Zelezna B, Fickova M, Macho L, Krizanova O, Jezova D . Elevated AT1 receptor protein but lower angiotensin II-binding in adipose tissue of rats with monosodium glutamate-induced obesity. Horm Metab Res. 2001; 33(12):708-12. DOI: 10.1055/s-2001-19132. View

20.

Janke J, Engeli S, Gorzelniak K, Luft F, Sharma A . Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes. 2002; 51(6):1699-707. DOI: 10.2337/diabetes.51.6.1699. View